NCT01492699View on ClinicalTrials.gov

Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Post Traumatic Stress Disorder
Interventions
DRUG

PRX-03140

50 mg PRX-03140 capsules once daily for 2 weeks. After 2 weeks, the dose will increase to 100mg PRX-03140 once daily for 10 weeks.

Trial Locations (1)

32607

Sarkis Clinical Trials, Gainesville

All Listed Sponsors
lead

Alachua Government Services, Inc.

INDUSTRY

NCT01492699 - Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder | Biotech Hunter | Biotech Hunter